Although interrupted, this trial provides an indication that Abeta immunotherapy may be useful in Alzheimer disease.
No takes yet. Share an insight, caveat, or question.
Gilman et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: